AGP Limited (PSX:AGP)
Pakistan · Delayed Price · Currency is PKR 192.16
-2.61 (-1.34%)
At close: Oct 21, 2025
AGP Limited Revenue
AGP Limited had revenue of 5.56B PKR in the quarter ending June 30, 2025, a decrease of -2.86%. This brings the company's revenue in the last twelve months to 26.11B, up 17.10% year-over-year. In the year 2024, AGP Limited had annual revenue of 25.03B with 33.56% growth.
Revenue (ttm)
26.11B
Revenue Growth
+17.10%
P/S Ratio
2.06
Revenue / Employee
12.18M
Employees
2,143
Market Cap
53.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.03B | 6.29B | 33.56% |
| Dec 31, 2023 | 18.74B | 4.28B | 29.63% |
| Dec 31, 2022 | 14.46B | 5.14B | 55.19% |
| Dec 31, 2021 | 9.32B | 2.37B | 34.12% |
| Dec 31, 2020 | 6.95B | 693.12M | 11.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 72.39B |
| GlaxoSmithKline Pakistan | 62.62B |
| The Searle Company | 28.60B |
| Shifa International Hospitals | 27.97B |
| Highnoon Laboratories | 25.78B |
| Ferozsons Laboratories | 18.86B |
| Citi Pharma | 13.15B |
| Macter International | 10.36B |